Skip to search formSkip to main contentSkip to account menu

CP 0127

Known as: CP-0127 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Early pharmacological treatment has the potential to reduce some of the disabling cognitive and behavioral problems that result… 
2005
2005
In search of new possibilities to prevent acute inflammatory vascular reaction, we examined the effect of two selective B2… 
1998
1998
Summary Focal cerebral contusions can be dynamic and expansive, leading to delayed neurological deterioration. Due to the high… 
Highly Cited
1997
Highly Cited
1997
OBJECTIVE To test the effect of a novel bradykinin antagonist, deltibant (CP-0127), on survival, organ dysfunction, and other… 
1994
1994
We studied the effects of CP-0127, a novel bradykinin receptor antagonist, in a rat model of traumatic shock. Pentobarbital… 
1992
1992
The bradykinin antagonist dimer CP-0127 was found to be a potent and selective inhibitor of the depressor response to bradykinin…